3M 2010 Annual Report Download - page 116

Download and view the complete annual report

Please find page 116 of the 2010 3M annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

110
retroreflective sheeting, entered into illegal and anticompetitive contracts, and engaged in other anticompetitive acts
including false advertising and disparagement. Avery's antitrust lawsuit follows a lawsuit that 3M filed earlier in 2010
against Avery in the United States District Court for the District of Minnesota claiming that Avery's OmniCube product
infringes certain 3M patent rights. 3M’s motion to preliminarily enjoin the sales of Avery’s OmniCube retroreflective
sheeting was denied in December 2010. 3M also filed suit in 2010 seeking a declaratory judgment that 3M’s
Diamond Grade DG3 full cube retroreflective sheeting does not infringe two Avery patents. In February 2011, the
United States District Judge for the Central District of California granted the Company’s motion to transfer Avery’s
antitrust lawsuit to the District of Minnesota.
In December 2010, Meda AB filed a lawsuit in the Supreme Court of the State of New York, County of New York,
alleging breach certain representations and warranties contained in the October 2006 acquisition agreement
pursuant to which Meda AB acquired the Company’s European pharmaceutical business. The lawsuit seeks to
recover an amount to be determined at trial, but not less than $200 million, in compensatory damages alleging that
3M failed to disclose, during the due diligence period, certain pricing arrangements between 3M’s French subsidiary
and the French government agency that determines the eligible levels of reimbursement for prescription
pharmaceuticals. As previously stated, the damage amounts specified in complaints are not a meaningful factor in
any assessment of the Company’s potential liability. The Company believes it has a number of legal and factual
defenses to this claim and will vigorously defend it.
No liability has been recorded for the Company’s commercial litigation described in this section because the
Company believes that liability is not probable and estimable at this time and the Company is not able to estimate a
possible loss or range of loss given the limited activity in these cases.
French Competition Authority Investigation
On December 4, 2008, the Company’s subsidiary in France (“3M France”) received a Statement of Objections from
the French Competition Authority (“FCA”) alleging an abuse of a dominant position regarding the supply of retro-
reflective films for vertical signing applications in France and participation in a concerted practice with the major
French manufacturers of vertical signs. On December 22, 2010, the FCA issued a decision finding that there was
insufficient evidence that 3M France participated in any such concerted practice. The FCA also found that 3M France
from 2003 to 2005 abused a dominant position on the French market for retro-reflective films intended for the
manufacturing of vertical signs through discriminatory rebates and characteristics of its accreditation system and
fined 3M France 1.97 million Euros. While the Company disagrees with the FCA’s decision on abuse of a dominant
position, the Company does not plan to appeal. The Company does not expect any additional litigation to arise from
the FCA decision.
NOTE 15. Employee Savings and Stock Ownership Plans
The Company sponsors employee savings plans under Section 401(k) of the Internal Revenue Code. These plans
are offered to substantially all regular U.S. employees. Effective January 1, 2010, substantially all Company
contributions are made in cash. During 2008 the Board of Directors approved various changes to the employee
savings plans. For substantially all employees hired prior to January 1, 2009, employee 401(k) contributions of up to
6% of eligible compensation are matched at rates of 60% or 75%, depending on the plan the employee participated
in. Employees hired on or after January 1, 2009 receive a cash match of 100% for employee 401(k) contributions of
up to 6% of eligible compensation and also receive an employer retirement income account cash contribution of 3%
of the participant’s total eligible compensation. All contributions are invested in a number of investment funds
pursuant to their elections.
The Company maintained an Employee Stock Ownership Plan (ESOP) that was established in 1989 as a cost-
effective way of funding the majority of the Company’s contributions under 401(k) employee savings plans. Total
ESOP shares were considered to be shares outstanding for earnings per share calculations. The ESOP debt
matured in 2009.
Dividends on shares held by the ESOP were paid to the ESOP trust and, together with Company contributions, were
used by the ESOP to repay principal and interest on the outstanding ESOP debt. The tax benefit related to dividends
paid on unallocated shares was charged directly to equity and totaled approximately $1 million in 2009 and $2 million
in 2008. Over the life of the ESOP debt, shares were released for allocation to participants based on the ratio of the
current year’s debt service to the remaining debt service prior to the current payment.
Until 2009, the ESOP was the primary funding source for the Company’s employee savings plans. As permitted by
accounting standards relating to employers’ accounting for employee stock ownership plans, the debt of the ESOP